Status:

RECRUITING

Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old

Lead Sponsor:

Centre Hospitalier Universitaire de Besancon

Conditions:

Child Behavior Disorders

Parent-Child Relations

Eligibility:

All Genders

Up to 3 years

Phase:

NA

Brief Summary

This study aims to assess the efficacy at 4 months of a personalized strategy comparatively to a standard Psychodynamic Integrative Therapy, on childrens' symptom improvment

Detailed Description

3 evaluations are performed: before treatment, at the end of the treatment and one year after the treatment. evaluations include assessment of: children's symptom parent-infant interaction quality pa...

Eligibility Criteria

Inclusion

  • Families who are requesting a consultation for functional or behavioural problems of their child
  • Children under the age of 3

Exclusion

  • Parents suffering from a severe untreated psychiatric disorder
  • Difficulties in speaking French
  • Children with Autistic spectrum disorder
  • Families already in care

Key Trial Info

Start Date :

February 28 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2026

Estimated Enrollment :

234 Patients enrolled

Trial Details

Trial ID

NCT05206708

Start Date

February 28 2022

End Date

August 1 2026

Last Update

September 19 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

CHU de Besançon

Besançon, France

2

CHU de Montpellier

Montpellier, France

3

GHU Paris Psychiatrie et Neurosciences

Paris, France

4

CHU de Reims

Reims, France

Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old | DecenTrialz